← back to search

Peter Frith

Flinders University · AU
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Medicine, Obstructive lung disease, COPD, Pulmonary disease, Intensive care medicine, and Humanities.
h-index
citations
8,483
works
11
NIH funding
primary concept
email

Recent publications

Pragmatic randomised controlled trial of a personalised intervention for carers of people requiring home oxygen therapy
Chronic Respiratory Disease 2020cited by 7position: firstdoi
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
European Respiratory Journal 2019cited by 1,956position: middledoi
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee
Annals of the American Thoracic Society 2018cited by 19position: middledoi
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine 2017cited by 3,233position: middledoi
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
European Respiratory Journal 2017cited by 878position: middledoi
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Respirology 2017cited by 694position: middledoi
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Archivos de Bronconeumología 2017cited by 631position: middledoi
Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
Archivos de Bronconeumología 2017cited by 313position: middledoi
Australian and <scp>N</scp>ew <scp>Z</scp>ealand <scp>P</scp>ulmonary <scp>R</scp>ehabilitation <scp>G</scp>uidelines
Respirology 2017cited by 307position: middledoi
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
European Respiratory Journal 2014cited by 170position: middledoi
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
The Lancet Respiratory Medicine 2013cited by 275position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dave Singh · University of York6 papers (2017–2019)María Victorina López Varela · Universidad de la República de Uruguay6 papers (2017–2019)Jørgen Vestbo · Manchester Academic Health Science Centre6 papers (2017–2019)Marc Decramer · University of British Columbia6 papers (2013–2017)Nicolás Roche · Hospital Universitario Fundación Jiménez Díaz6 papers (2017–2019)Jadwiga A. Wedzicha · Imperial College London6 papers (2017–2019)Bartolomé R. Celli · Harvard University6 papers (2017–2019)Gerard J. Criner · Temple University Hospital6 papers (2017–2019)Robert A. Stockley · University Hospitals Birmingham NHS Foundation Trust6 papers (2017–2019)Jean Bourbeau · McGill University Health Centre6 papers (2017–2019)Peter J. Barnes · The London College6 papers (2017–2019)David Halpin · University of Exeter6 papers (2017–2019)Antonio Anzueto · The University of Texas Health Science Center at San Antonio6 papers (2017–2019)Àlvar Agustí · British Lung Foundation6 papers (2017–2019)Claus Vogelmeier · German Center for Lung Research6 papers (2017–2019)Masaharu Nishimura · Hokkaido Institute of Public Health5 papers (2017–2017)Fernando J. Martínez · University of Massachusetts Chan Medical School5 papers (2017–2019)Leonardo M. Fabbri · University of Ferrara5 papers (2017–2017)Don D. Sin · University of British Columbia5 papers (2017–2017)Roberto Rodríguez-Roisin · Royal College of Surgeons in Ireland4 papers (2017–2017)